US Stock MarketDetailed Quotes

Enanta Pharmaceuticals (ENTA)

Watchlist
  • 12.200
  • -0.320-2.56%
Close Sep 18 16:00 ET
  • 12.200
  • 0.0000.00%
Post 19:30 ET
355.33MMarket Cap-5.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enanta Pharmaceuticals (ENTA) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q3
Stock NameRevenueRatio
Discovering and developing small molecule drugs with an emphasis on virology and immunology14.36M100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States65.32M100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.13%
Sample Name
Sample Code
 +15.83%
Sample Name
Sample Code
 +14.33%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+13.30%
5
United Sts Brent Oil Fd Lp Unit
BNO
+13.24%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +8.70%
Sample Name
Sample Code
 +6.46%
Sample Name
Sample Code
 +6.39%
4
ASE Technology
ASX
+5.47%
5
Trip.com
TCOM
+4.25%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -